dc.contributor.author | Zeissler, M | |
dc.contributor.author | Windle, R | |
dc.contributor.author | McFarthing, K | |
dc.contributor.author | Raphael, K | |
dc.contributor.author | Rafaloff, G | |
dc.contributor.author | Carroll, Camille | |
dc.date.accessioned | 2021-08-09T12:36:04Z | |
dc.date.available | 2021-08-09T12:36:04Z | |
dc.date.issued | 2020-09 | |
dc.identifier.uri | http://hdl.handle.net/10026.1/17495 | |
dc.language.iso | en | |
dc.title | Using a Delphi process to inform the design of disease modifying trials in Parkinson's disease | |
dc.type | presentation | |
plymouth.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000567989802082&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008 | |
plymouth.organisational-group | /Plymouth | |
plymouth.organisational-group | /Plymouth/Faculty of Health | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy | |
plymouth.organisational-group | /Plymouth/Research Groups | |
plymouth.organisational-group | /Plymouth/Research Groups/FoH - Applied Parkinson's Research | |
plymouth.organisational-group | /Plymouth/Research Groups/FoH - Community and Primary Care | |
plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED) | |
plymouth.organisational-group | /Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CCT&PS | |
plymouth.organisational-group | /Plymouth/Users by role | |
plymouth.organisational-group | /Plymouth/Users by role/Academics | |
dc.publisher.place | Movement-Disorder-Society (MDS) International Virtual Congress | |
dc.rights.embargoperiod | Not known | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.type | Other | |